In vitro activity of nanoliposomal amphotericin B against terbinafine-resistant Trichophyton indotineae isolates

Mohsen Nosratabadi,Javad Akhtari,Mahmoud Reza Jaafari,Zahra Yahyazadeh,Tahereh Shokohi,Iman Haghani,Pardis Farmani,Robab Ebrahimi Barough,Hamid Badali,Mahdi Abastabar
DOI: https://doi.org/10.1007/s10123-024-00617-4
2024-12-01
International Microbiology
Abstract:Background The emergence of resistance in dermatophytes underscores the necessity for developing novel and alternative treatment options. Methods The present study aimed to evaluate the in vitro activity of nanoliposomal amphotericin B against a large panel of terbinafine-resistant Trichophyton indotineae isolates. In vitro susceptibility testing of nanoliposomal amphotericin B and comparators against 50 clinical isolates of terbinafine-resistant T. indotineae strains was performed by broth microdilution according to the Clinical and Laboratory Standards Institute (CLSI) M38-A3 document. Results The highest MIC 90 and widest MIC range were found for terbinafine (4 and ≥ 4 μg/ml) followed by itraconazole (0.5 and 0.016–16 μg/ml). In contrast, the nanoliposomal amphotericin B and conventional amphotericin B exhibited low MIC 90 (0.5 μg/ml) and MIC range (0.25–0.5 μg/ml). Conclusions The study findings revealed that nanoliposomal amphotericin B might be a promising candidate against terbinafine-resistant strains of T. indotineae . However, further studies are required to pave the way for developing novel antifungal compounds to combat fungal resistance.
microbiology,biotechnology & applied microbiology
What problem does this paper attempt to address?